A fermenter and a graphic
Company

Bio-based products and solutions for a bio-based future

We are a specialist in industrial biotechnology and want to help drive a bio-based future.

The bio-based future is based on a society, economy and politics that have switched away from fossil carbon and turned to alternative products and processes. In a bio-based future, industry manufactures or produces e.g. materials, chemicals and energy based on renewable biological resources.

With our innovative products and solutions for nutrition, health and the environment, we support industry in its efforts to create processes and products that are more sustainable. We rely on biotechnology as a tool for developing the bioeconomy – and creating a bio-based future.

Why work with us?

  • Interdisciplinary, experienced project teams: Our scientists work side by side with our experts for the respective industrial application. Their in-depth understanding of technology and many years of application experience are incorporated into the goal-oriented project design. In addition, we have gained experience from more than 50 exclusive upscale projects.
  • Access to BRAIN Bioarchive / SeqPool: We offer our customers access to the BRAIN Bioarchive, a comprehensive collection of microorganisms and natural substances. The collection, which is constantly being expanded by the BRAIN Group, also contains fractions from edible plant materials, metagenome and enzyme libraries, and complete metabolic pathways including previously unculturable organisms.
  • High-yielding host organisms: We hold high-yielding host organisms (fungi, bacteria and yeasts), and we have industrial-scale fermentation/production capabilities at our UK site.
  • Broad technology portfolio: including protein engineering, genome editing (with proprietary BRAIN Cas nucleases), metagenome technologies, next-generation sequencing, precision fermentation, applied bioinformatics, 3D modeling, instrumental analytics.
  • Adding value: Solution-oriented, always keeping our customers' requirements in mind, we contribute to adding value – from concept to production and beyond.

Fermentation at Biocatalysts
© Biocatalysts

Group capabilities

All companies in the BRAIN Group act as interconnected entities in the fields of research and development, process development and production, or as suppliers in specialty markets.

BRAIN Group

A part of the BRAIN Bauhaus building, with a graphical element

Driving innovation

BRAIN Biotech AG in Zwingenberg, Germany, serves as the headquarter of the BRAIN Group. Ever since its inception in 1993, it has been a driver and high-tech pioneer of the industrial biotechnology and a sustainable bioeconomy.

BRAIN Biotech AG

BRAIN Biotech in figures

>29
More than 29 years
of biotech experience
>35
Over 35 years enzyme
manufacturing experience
~330
employees in
the BRAIN Group
~350
specialty products for B2B business
>50
active patent families with varying numbers of individual patents
38.4
million euro revenue in FY 2020/21

Our products & services

Product sales

The BRAIN Group offers around 350 ready to buy specialty products for B2B. These comprise customized enzymes, bioactive natural compounds and high-performance microorganisms. This portfolio is constantly fueled by project realizations from our New Business Development pipeline.

Products & Markets

Breakthroughs & Services

BRAIN Biotech AG has a long track record of dedicated contract R&D programs with industry partners. We offer joint development of customer-specific solutions and exclusive R&D partnerships. Together with industrial partners we also develop new product candidates.

Services

Meet BRAIN at


Congress

4th Bioeconomy Congress Baden-Württemberg

26 September 2022
Details

Conference

Key Technologies in the Bioeconomy

27 September 2022
Details

Workshop

IWBio Workshop “Digitization in Industrial Biotechnology”

29 September 2022
Details

Forum

IFIB – International Forum on Industrial Biotechnology and Bioeconomy

29 September 2022
Details

News & Views


6 July 2022

"An ESG report should not be justified in itself"

Show article

7 February 2022
white bread

BRAIN Group expands its food enzymes business

Show article

17 January 2022
GB 20_21

Annual Report for FY 2020/21 has been published

Show article

Learn more about BRAIN


BRAIN Graphic
BRAIN for Investors

Headerpicture
Careers at BRAIN

BRAIN Media

Share this page